In a very recent study employing a global antibody profiling strategy to identify novel antibodies as possible biomarkers in SSc, Liang et al.[64] found a significant increase in antiprotein arginine methyltransferase 5 (PRMT5) antibody among SSc patients. Here, PRMT5 is linked to systemic sclerosis.